YbaƱez, Conchita N.

HRN: 22-17-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/05/2022
11/11/2022
IV
1.5G
Q6
Wound Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: